Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis

Allergic bronchopulmonary aspergillosis (ABPA) is a disease characterized by severe disability with recurrent wheezing and shortness of breath. The current recommended therapy is daily oral corticosteroids +/− oral antifungal therapy. Despite this, many patients continue to have severe symptoms, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Muhammad, Green, O’Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081018/
https://www.ncbi.nlm.nih.gov/pubmed/33948179
http://dx.doi.org/10.1093/omcr/omaa029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081018/
https://www.ncbi.nlm.nih.gov/pubmed/33948179
http://dx.doi.org/10.1093/omcr/omaa029

Ejemplares similares